ARTICLE | Company News
Chaperone Technologies, MerLion deal
December 14, 2009 8:00 AM UTC
The companies will evaluate the combination of Chaperone's preclinical small molecule heat shock protein 70 (Hsp70) inhibitors with MerLion's finafloxacin as potential treatments for bacterial infect...